Immune Globulin Intravenous Market Report

Global and Region Immune Globulin Intravenous Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：219
  • REPORT CODE：GMM1020971
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Immune Globulin Intravenous market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Immune Globulin Intravenousmarket, defines the market attractiveness level of Immune Globulin Intravenous market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Immune Globulin Intravenous industry, describes the types of Immune Globulin Intravenous market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immune Globulin Intravenous market and the development prospects and opportunities of Immune Globulin Intravenous industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immune Globulin Intravenous market in Chapter 13.

    By Player:

    • Sichuan Yuanda Shuyang

    • Baxter

    • Biotest

    • Shanghai RAAS

    • CBPO

    • LFB Group

    • CNBG

    • Hualan Bio

    • Octapharma

    • CSL

    • Kedrion

    • BPL

    • Grifols

    By Type:

    • IVIg Liquid

    • IVIg Powder

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Immune Globulin Intravenous Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Immune Globulin Intravenous Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Immune Globulin Intravenous Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Immune Globulin Intravenous Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Immune Globulin Intravenous Market Analysis and Outlook to 2022

    • 7.1 Global Immune Globulin Intravenous Consumption (2017-2022)

    • 7.2 United States Immune Globulin Intravenous Consumption (2017-2022)

    • 7.3 Europe Immune Globulin Intravenous Consumption (2017-2022)

    • 7.4 China Immune Globulin Intravenous Consumption (2017-2022)

    • 7.5 Japan Immune Globulin Intravenous Consumption (2017-2022)

    • 7.6 India Immune Globulin Intravenous Consumption (2017-2022)

    • 7.7 South Korea Immune Globulin Intravenous Consumption (2017-2022)

    8 Region and Country-wise Immune Globulin Intravenous Market Analysis and Outlook to 2028

    • 8.1 Global Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.2 United States Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.3 Europe Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.4 China Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.5 Japan Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.6 India Immune Globulin Intravenous Consumption Forecast (2022-2028)

    • 8.7 South Korea Immune Globulin Intravenous Consumption Forecast (2022-2028)

    9 Global Immune Globulin Intravenous Market Outlook by Types and Applications to 2022

    • 9.1 Global Immune Globulin Intravenous Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global IVIg Liquid Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global IVIg Powder Consumption and Growth Rate (2017-2022)

    • 9.2 Global Immune Globulin Intravenous Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunodeficiency Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Acute Infection Consumption and Growth Rate (2017-2022)

    10 Global Immune Globulin Intravenous Market Outlook by Types and Applications to 2028

    • 10.1 Global Immune Globulin Intravenous Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global IVIg Liquid Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global IVIg Powder Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Immune Globulin Intravenous Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    11 Global Immune Globulin Intravenous Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Immune Globulin Intravenous Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Immune Globulin Intravenous Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Immune Globulin Intravenous Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Immune Globulin Intravenous Market Competitive Analysis

    • 14.1 Sichuan Yuanda Shuyang

      • 14.1.1 Sichuan Yuanda Shuyang Company Details

      • 14.1.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Service

    • 14.2 Baxter

      • 14.2.1 Baxter Company Details

      • 14.2.2 Baxter Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Baxter Immune Globulin Intravenous Product and Service

    • 14.3 Biotest

      • 14.3.1 Biotest Company Details

      • 14.3.2 Biotest Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biotest Immune Globulin Intravenous Product and Service

    • 14.4 Shanghai RAAS

      • 14.4.1 Shanghai RAAS Company Details

      • 14.4.2 Shanghai RAAS Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Shanghai RAAS Immune Globulin Intravenous Product and Service

    • 14.5 CBPO

      • 14.5.1 CBPO Company Details

      • 14.5.2 CBPO Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CBPO Immune Globulin Intravenous Product and Service

    • 14.6 LFB Group

      • 14.6.1 LFB Group Company Details

      • 14.6.2 LFB Group Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 LFB Group Immune Globulin Intravenous Product and Service

    • 14.7 CNBG

      • 14.7.1 CNBG Company Details

      • 14.7.2 CNBG Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 CNBG Immune Globulin Intravenous Product and Service

    • 14.8 Hualan Bio

      • 14.8.1 Hualan Bio Company Details

      • 14.8.2 Hualan Bio Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Hualan Bio Immune Globulin Intravenous Product and Service

    • 14.9 Octapharma

      • 14.9.1 Octapharma Company Details

      • 14.9.2 Octapharma Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Octapharma Immune Globulin Intravenous Product and Service

    • 14.10 CSL

      • 14.10.1 CSL Company Details

      • 14.10.2 CSL Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CSL Immune Globulin Intravenous Product and Service

    • 14.11 Kedrion

      • 14.11.1 Kedrion Company Details

      • 14.11.2 Kedrion Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Kedrion Immune Globulin Intravenous Product and Service

    • 14.12 BPL

      • 14.12.1 BPL Company Details

      • 14.12.2 BPL Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 BPL Immune Globulin Intravenous Product and Service

    • 14.13 Grifols

      • 14.13.1 Grifols Company Details

      • 14.13.2 Grifols Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Grifols Immune Globulin Intravenous Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Immune Globulin Intravenous

    • Figure Immune Globulin Intravenous Picture

    • Table Global Immune Globulin Intravenous Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immune Globulin Intravenous Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immune Globulin Intravenous Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Immune Globulin Intravenous Consumption by Country (2017-2022)

    • Figure United States Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Table Europe Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Figure China Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Japan Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Figure India Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Figure South Korea Immune Globulin Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Immune Globulin Intravenous Consumption Forecast by Country (2022-2028)

    • Figure United States Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Immune Globulin Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IVIg Liquid Consumption and Growth Rate (2017-2022)

    • Figure Global IVIg Powder Consumption and Growth Rate (2017-2022)

    • Figure Global Immunodeficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Infection Consumption and Growth Rate (2017-2022)

    • Figure Global IVIg Liquid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IVIg Powder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Immune Globulin Intravenous Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Immune Globulin Intravenous Export by Region (Top 5 Countries) (2017-2028)

    • Table Sichuan Yuanda Shuyang (Foundation Year, Company Profile and etc.)

    • Table Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Immune Globulin Intravenous Product and Service

    • Table Biotest (Foundation Year, Company Profile and etc.)

    • Table Biotest Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotest Immune Globulin Intravenous Product and Service

    • Table Shanghai RAAS (Foundation Year, Company Profile and etc.)

    • Table Shanghai RAAS Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai RAAS Immune Globulin Intravenous Product and Service

    • Table CBPO (Foundation Year, Company Profile and etc.)

    • Table CBPO Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table CBPO Immune Globulin Intravenous Product and Service

    • Table LFB Group (Foundation Year, Company Profile and etc.)

    • Table LFB Group Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table LFB Group Immune Globulin Intravenous Product and Service

    • Table CNBG (Foundation Year, Company Profile and etc.)

    • Table CNBG Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table CNBG Immune Globulin Intravenous Product and Service

    • Table Hualan Bio (Foundation Year, Company Profile and etc.)

    • Table Hualan Bio Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Bio Immune Globulin Intravenous Product and Service

    • Table Octapharma (Foundation Year, Company Profile and etc.)

    • Table Octapharma Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma Immune Globulin Intravenous Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Immune Globulin Intravenous Product and Service

    • Table Kedrion (Foundation Year, Company Profile and etc.)

    • Table Kedrion Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kedrion Immune Globulin Intravenous Product and Service

    • Table BPL (Foundation Year, Company Profile and etc.)

    • Table BPL Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table BPL Immune Globulin Intravenous Product and Service

    • Table Grifols (Foundation Year, Company Profile and etc.)

    • Table Grifols Immune Globulin Intravenous Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Immune Globulin Intravenous Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US